We are live on ! Find out more
COCH icon

Envoy Medical
COCH

94 hedge funds and large institutions have $362M invested in Envoy Medical in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 7

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

9% more capital invested

Capital invested by funds: $331M → $362M (+$30.8M)

6.7% more ownership

Funds ownership: 80.61% → 87.31% (+6.7%)

6% more funds holding

Funds holding: 89 → 94 (+5)

Holders
94
Holders Change
+5
Holders Change %
+5.62%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
23
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$11.1M
2
MF
Magnetar Financial
Illinois
+$10.7M
3
Millennium Management
Millennium Management
New York
+$6.72M
4
DCM
Difesa Capital Management
New York
+$3.08M
5
HCM
Highbridge Capital Management
New York
+$2.95M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$9.06M
2
HI
HBK Investments
Texas
-$7.5M
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$3.52M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.94M
5
PMAM
Picton Mahoney Asset Management
Ontario, Canada
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCL
1
Glazer Capital LLC
New York
$33.6M +$384K +39,101 +1%
AC
2
Aristeia Capital
Connecticut
$27.1M – – –
Marshall Wace
3
Marshall Wace
United Kingdom
$20.5M – – –
Millennium Management
4
Millennium Management
New York
$18.9M +$6.72M +684,319 +55%
Nomura Holdings
5
Nomura Holdings
Japan
$18.8M – – –
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$14.7M – – –
MF
7
Magnetar Financial
Illinois
$14M +$10.7M +1,091,979 +333%
SCM
8
Saba Capital Management
New York
$13.3M +$1.23M +125,000 +10%
PC
9
Periscope Capital
Ontario, Canada
$12.4M +$1.9M +193,565 +18%
FTCM
10
Fir Tree Capital Management
New York
$11.6M – – –
DAM
11
DLD Asset Management
New York
$11.4M – – –
HSBC Holdings
12
HSBC Holdings
United Kingdom
$10.3M – – –
BNP Paribas Financial Markets
13
BNP Paribas Financial Markets
France
$8.37M +$11.1M +1,133,333 New
Hudson Bay Capital Management
14
Hudson Bay Capital Management
Connecticut
$6.88M – – –
TCA
15
Taconic Capital Advisors
New York
$6.59M +$1.37M +140,000 +26%
SC
16
Sculptor Capital
New York
$6.12M +$137K +13,939 +2%
RCM
17
Radcliffe Capital Management
Pennsylvania
$5.72M +$809K +82,364 +16%
WA
18
Whitebox Advisors
Minnesota
$5.42M – – –
Citadel Advisors
19
Citadel Advisors
Florida
$4.92M +$167 +17 +0%
KL
20
KIM LLC
Kansas
$4.92M – – –
MCM
21
Moore Capital Management
New York
$4.92M – – –
VI
22
Vestcor Inc
New Brunswick, Canada
$4.92M – – –
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$4.72M +$491K +50,000 +12%
WP
24
Woodline Partners
California
$4.67M – – –
WCMNY
25
Westchester Capital Management (New York)
New York
$4.49M – – –
1
2 3 4 5

COCH Hedge Fund Activity: Q3 2022 in Review

94 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q3 2022, worth a combined $362M — up 9.3% from $331M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new COCH positions and 9 closed out — a net gain of 5 holders — while 23 added to existing stakes and 7 trimmed.

The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $11.1M. The largest seller was Goldman Sachs, cutting an estimated $9.06M.

  • 94 institutional investors held Envoy Medical (COCH) as of Q3 2022, up from 89 in Q2 2022.
  • Funds reported $362M of Envoy Medical stock for Q3 2022, up 9.3% quarter-over-quarter.
  • 14 funds opened new Envoy Medical positions in Q3 2022 and 9 closed out, a net change of +5 holders.
  • The largest Envoy Medical buyer in Q3 2022 was BNP Paribas Financial Markets, an estimated $11.1M added.
  • The largest Envoy Medical seller in Q3 2022 was Goldman Sachs, an estimated $9.06M sold.

Based on aggregated 13F filings for Q3 2022.